Evidence map›Paper›PMID 40016572›Full record

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2025

Practical Approaches to Continuous Glucose Monitoring in Primary Care: A UK-Based Consensus Opinion.

Kevin Fernando, Vicki Alabraba, John B Welsh, Samuel Seidu, W David Strain, Heather Elizabeth Bell, Sarah Davies, Marc Evans

Abstract read
In one paragraph

Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kevin FernandoNorth Berwick Health Centre, North Berwick, UK.ORCID http://orcid.org/0000-0003-1127-4886
Vicki AlabrabaLeicester Diabetes Centre, University Hospitals Leicester NHS Trust and Pinfold Medical Practice, Loughborough, UK.
John B WelshDexcom, Inc., San Diego, CA, USA. john.welsh@dexcom.com.ORCID http://orcid.org/0000-0001-9243-5228
Samuel SeiduUniversity of Leicester, Leicester, UK.
W David StrainRoyal Devon & Exeter Hospital, Exeter, UK.
Heather Elizabeth BellOld School Surgery, Greenisland, Northern Ireland, UK.
Sarah DaviesWoodlands Medical Centre, Cardiff, UK.
Marc EvansUniversity Hospital Llandough, Cardiff, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionType 2 diabetes (T2D) imposes significant personal challenges and societal costs. Continuous glucose monitoring (CGM) is recognised as a state-of-the-art tool, but remains underutilised. Adoption of CGM in primary care should be informed by a broader understanding of the technology's capabilities and limitations.

methodsAn expert panel was convened to review current literature and clinical experience to provide practical approaches to CGM for primary care practitioners and discuss the technology's value in the routine management of T2D. The goals were to review and reach consensus on the current state of CGM in non-specialist practice settings and on strategies for successfully initiating and maintaining people on CGM.

resultsInitiation and maintenance of CGM therapy can be successfully conducted in primary care settings. CGM therapy should include proper patient selection, proper setting of expectations, and evidence-based adjustments to therapy. Most patients are likely to see quick, meaningful, and lasting improvements in their diabetes, along with a better understanding of their condition and greater motivation for successful management. Retrospective report interpretation is feasible and intuitive. Barriers to adoption and sustained use include cost, technological limitations, behavioural or psychological factors, and therapeutic inertia. Addressing these barriers is critical to enable better access to CGM. Continuous glucose monitoring can be leveraged by primary care teams to inform treatment decisions and also by patients to inform diabetes self-management.

conclusionCGM should be considered for all people with T2D. The recommendations provided here should simplify adoption and maintenance use of CGM in primary care and maximise the glycaemic and psychosocial benefits of the technology.

Indexed as

Consensus opinionContinuous glucose monitoringPrimary careType 2 diabetes

Identifiers

PMID40016572
PMCPMC11925819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.